We use cookies to ensure that we give you the best experience on our website Learn more

Home

Saved research

Submission

02 / HUMAN PAPILLOMAVIRUS VACCINE UPTAKE AMONG YOUNG GAY AND BISEXUAL MEN WHO HAVE SEX WITH MEN WITH A TARGETED PROGRAMME THROUGH SEXUAL HEALTH SERVICES IN MELBOURNE, AUSTRALIA

Submitted

and 1 other(s)

0 Views
0 Downloads
0 Saves

Presented at

IUSTI 2018 World +European Congress

-

Presentation

thumbnail

Abstract

Background: In mid-2017, the Victorian Government funded a free human papillomavirus (HPV) vaccination catch-up programme for men who have sex with men (MSM) aged up to 26 years through sexual health clinics or other immunisation centres. We aimed to examine the uptake of the HPV vaccine among young MSM attending the Melbourne Sexual Health Clinic (MSHC). Methods: MSM aged ≤26 attending MSHC between 27-April-2017 and 31-December-2017 were included in the analysis. HPV vaccine uptake was calculated based on the first consultation of each client during the period. Multivariable logistic regression was performed to examine the association between vaccine uptake and client factors. Results: There were 2108 MSM aged ≤26 attended MSHC over the study period with 7.6% (n=161) reporting previous HPV vaccination. Of the 1947 eligible men, 1134 (58.2%, 95% CI: 56.0% to 60.4%) were offered the vaccine, and 830 (42.6%, 95% CI: 40.4% to 44.9%) received it on the day. Men with a history of genital warts (adjusted odds ratio [aOR]=3.12, 95% CI: 1.39 to 7.00) and those who had >4 male partners in last 12 months (aOR=1.38, 95% CI: 1.04 to 1.85) were more likely to receive the HPV vaccine on the day. There were 304 MSM declined the vaccine, most men did not specify the reason (31.3%, n=95) and 27.3% needed time to think (n=83). Conclusions: Although vaccine uptake was 73.2% among those offered, the actual coverage in those eligible remained unsatisfactory (42.1%) in a sexual health clinic. This highlights a clinic-based targeted MSM programme may not reach sufficiently high vaccine coverage to provide MSM with the same vaccine benefits as heterosexuals.

Datasets

No datasets are available for this submission.

License

No license information is available for this submission.

Morressier

Company

Legal

Follow us

© Copyright 2021 Morressier GmbH. All rights reserved.

Morressier

© Copyright 2021 Morressier GmbH.
All rights reserved.